Certara Products - Simcyp Archives | Page 6 of 22 | サターラ

On-Demand Webinar

小児用医薬品開発におけるPBPKモデリングの適用に関するベストプラクティスフレームワーク

Pediatric PBPK models have broad application in the drug development process and are being used…

Certara2021年4月20日

White Paper

Overcome Research Hurdles: Expert Guidance for Complex Generic Drug Development

Do expensive bioequivalence studies stall your generic drug approval? Learn how you can streamline complex…

Certara2021年4月15日

On-Demand Webinar

Predicting the Effect of the Dulaglutide-Mediated Gastric Emptying Delay on Drug Exposure

The European Medicines Agency (EMA) recently approved dulaglutide (Trulicity®) at higher doses (3 mg and…

Certara2021年4月1日

Blog

Simcyp Simulator Impacts 80+ Novel Drugs

250 Label claims using PBPK without the need for additional clinical studies “Clinical Studies and…

Certara2021年3月17日

Publication

Physiologically- based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%

Certara2021年3月16日

On-Demand Webinar

IQ WG Evaluation of PBPK Models for Organ-Impaired Populations

• The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment…

Certara2021年3月10日

White Paper

Simcyp PBPK を用いた小児用医薬品開発の促進

Certara2021年3月4日

Brochure

Simcyp™ PBPK Simulator

Streamlines drug development by using PBPK modeling to predict drug behavior in virtual populations, optimize…

Certara2021年1月22日

Publication

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

Certara2020年11月13日

Press Coverage

薬物間相互作用試験の代わりに、PBPKモデリングをどのように使用できるか

Patients often take more than one drug at a time, especially elderly patients and those…

Certara2020年11月12日

© 2025 Certara. All Rights Reserved. | 個人情報保護

Powered by Translations.com GlobalLink Web Software